# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Sep 26, 2025

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2025-09-26
- Accepted by EDGAR: Sep 26, 2025, 06:01 ET
- Period: 2025-09-26
- Accession: 0001193805-25-001368
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380525001368/e664858_8k-arct.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380525001368/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380525001368/e664858_8k-arct.htm

Filed Sep 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001193805-25-001368. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
